Hari Madhav

6PUBLICATIONS
10CO-AUTHORS
Biomolecular modelling and designMolecular medicineBiologically active moleculesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 05, 2026
Development of substituted 2-(4-(sulfonyl)piperazin-1-yl)quinazoline molecular hybrids as a new class of antimalarials.

Hari Madhav, Ashutosh Panda, Dipanwita Datta

|Mar 22, 2024
Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of Plasmodial cysteine protease inhibitors for the treatment of malaria.

Hari Madhav, G Srinivas Reddy, Zeba Rizvi

|Dec 18, 2023
Naphthyl bearing 1,3,4-thiadiazoleacetamides targeting the parasitic folate pathway as anti-infectious agents: in silico, synthesis, and biological approach.

Kavita Pal, Sahil Lala, Priyanka Agarwal

|Jun 29, 2023
Design, synthesis, and biological evaluation of morpholinopyrimidine derivatives as anti-inflammatory agents.

Sadaf Fatima, Almaz Zaki, Hari Madhav

|Mar 27, 2023
Identification of new oxospiro chromane quinoline-carboxylate antimalarials that arrest parasite growth at ring stage.

Ehtesham Jameel, Hari Madhav, Prakhar Agrawal

|Apr 18, 2022
Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.

Hari Madhav, Ehtesham Jameel, Mohammad Rehan

Pageof 1

Frequent Collaborators

6 joint publications

Nasimul Hoda

2 joint publications

Ehtesham Jameel

2 joint publications

Tarosh S Patel

1 joint publications

Mohammad Rehan